A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
This report aims to provide a comprehensive presentation of the global market for Neurological Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurological Biomarkers. This report contains market size and forecasts of Neurological Biomarkers in global, including the following market information:
Global Neurological Biomarkers Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Neurological Biomarkers Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Neurological Biomarkers companies in 2022 (%)
The global Neurological Biomarkers market was valued at US$ 7137.8 million in 2022 and is projected to reach US$ 15280 million by 2029, at a CAGR of 11.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
We surveyed the Neurological Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurological Biomarkers Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurological Biomarkers Market Segment Percentages, by Type, 2022 (%)
Proteomics
Genomics
Imaging
Bioinformatics
Others
Global Neurological Biomarkers Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurological Biomarkers Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Drug Discovery
Personalized Medicine
Others
Global Neurological Biomarkers Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurological Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurological Biomarkers revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Neurological Biomarkers revenues share in global market, 2022 (%)
Key companies Neurological Biomarkers sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Neurological Biomarkers sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neurological Biomarkers, market overview.
Chapter 2: Global Neurological Biomarkers market size in revenue and volume.
Chapter 3: Detailed analysis of Neurological Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neurological Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Neurological Biomarkers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Neurological Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurological Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurological Biomarkers Overall Market Size
2.1 Global Neurological Biomarkers Market Size: 2022 VS 2029
2.2 Global Neurological Biomarkers Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Neurological Biomarkers Sales: 2018-2029
3 Company Landscape
3.1 Top Neurological Biomarkers Players in Global Market
3.2 Top Global Neurological Biomarkers Companies Ranked by Revenue
3.3 Global Neurological Biomarkers Revenue by Companies
3.4 Global Neurological Biomarkers Sales by Companies
3.5 Global Neurological Biomarkers Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Neurological Biomarkers Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Neurological Biomarkers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neurological Biomarkers Players in Global Market
3.8.1 List of Global Tier 1 Neurological Biomarkers Companies
3.8.2 List of Global Tier 2 and Tier 3 Neurological Biomarkers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurological Biomarkers Market Size Markets, 2022 & 2029
4.1.2 Proteomics
4.1.3 Genomics
4.1.4 Imaging
4.1.5 Bioinformatics
4.1.6 Others
4.2 By Type - Global Neurological Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Neurological Biomarkers Revenue, 2018-2023
4.2.2 By Type - Global Neurological Biomarkers Revenue, 2024-2029
4.2.3 By Type - Global Neurological Biomarkers Revenue Market Share, 2018-2029
4.3 By Type - Global Neurological Biomarkers Sales & Forecasts
4.3.1 By Type - Global Neurological Biomarkers Sales, 2018-2023
4.3.2 By Type - Global Neurological Biomarkers Sales, 2024-2029
4.3.3 By Type - Global Neurological Biomarkers Sales Market Share, 2018-2029
4.4 By Type - Global Neurological Biomarkers Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurological Biomarkers Market Size, 2022 & 2029
5.1.2 Diagnostics
5.1.3 Drug Discovery
5.1.4 Personalized Medicine
5.1.5 Others
5.2 By Application - Global Neurological Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Neurological Biomarkers Revenue, 2018-2023
5.2.2 By Application - Global Neurological Biomarkers Revenue, 2024-2029
5.2.3 By Application - Global Neurological Biomarkers Revenue Market Share, 2018-2029
5.3 By Application - Global Neurological Biomarkers Sales & Forecasts
5.3.1 By Application - Global Neurological Biomarkers Sales, 2018-2023
5.3.2 By Application - Global Neurological Biomarkers Sales, 2024-2029
5.3.3 By Application - Global Neurological Biomarkers Sales Market Share, 2018-2029
5.4 By Application - Global Neurological Biomarkers Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Neurological Biomarkers Market Size, 2022 & 2029
6.2 By Region - Global Neurological Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Neurological Biomarkers Revenue, 2018-2023
6.2.2 By Region - Global Neurological Biomarkers Revenue, 2024-2029
6.2.3 By Region - Global Neurological Biomarkers Revenue Market Share, 2018-2029
6.3 By Region - Global Neurological Biomarkers Sales & Forecasts
6.3.1 By Region - Global Neurological Biomarkers Sales, 2018-2023
6.3.2 By Region - Global Neurological Biomarkers Sales, 2024-2029
6.3.3 By Region - Global Neurological Biomarkers Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Neurological Biomarkers Revenue, 2018-2029
6.4.2 By Country - North America Neurological Biomarkers Sales, 2018-2029
6.4.3 US Neurological Biomarkers Market Size, 2018-2029
6.4.4 Canada Neurological Biomarkers Market Size, 2018-2029
6.4.5 Mexico Neurological Biomarkers Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Neurological Biomarkers Revenue, 2018-2029
6.5.2 By Country - Europe Neurological Biomarkers Sales, 2018-2029
6.5.3 Germany Neurological Biomarkers Market Size, 2018-2029
6.5.4 France Neurological Biomarkers Market Size, 2018-2029
6.5.5 U.K. Neurological Biomarkers Market Size, 2018-2029
6.5.6 Italy Neurological Biomarkers Market Size, 2018-2029
6.5.7 Russia Neurological Biomarkers Market Size, 2018-2029
6.5.8 Nordic Countries Neurological Biomarkers Market Size, 2018-2029
6.5.9 Benelux Neurological Biomarkers Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Neurological Biomarkers Revenue, 2018-2029
6.6.2 By Region - Asia Neurological Biomarkers Sales, 2018-2029
6.6.3 China Neurological Biomarkers Market Size, 2018-2029
6.6.4 Japan Neurological Biomarkers Market Size, 2018-2029
6.6.5 South Korea Neurological Biomarkers Market Size, 2018-2029
6.6.6 Southeast Asia Neurological Biomarkers Market Size, 2018-2029
6.6.7 India Neurological Biomarkers Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Neurological Biomarkers Revenue, 2018-2029
6.7.2 By Country - South America Neurological Biomarkers Sales, 2018-2029
6.7.3 Brazil Neurological Biomarkers Market Size, 2018-2029
6.7.4 Argentina Neurological Biomarkers Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Neurological Biomarkers Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Neurological Biomarkers Sales, 2018-2029
6.8.3 Turkey Neurological Biomarkers Market Size, 2018-2029
6.8.4 Israel Neurological Biomarkers Market Size, 2018-2029
6.8.5 Saudi Arabia Neurological Biomarkers Market Size, 2018-2029
6.8.6 UAE Neurological Biomarkers Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Neurological Biomarkers Major Product Offerings
7.1.4 Thermo Fisher Scientific Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Neurological Biomarkers Major Product Offerings
7.2.4 Merck Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Quest Diagnostics
7.3.1 Quest Diagnostics Company Summary
7.3.2 Quest Diagnostics Business Overview
7.3.3 Quest Diagnostics Neurological Biomarkers Major Product Offerings
7.3.4 Quest Diagnostics Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.3.5 Quest Diagnostics Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Neurological Biomarkers Major Product Offerings
7.4.4 Abbott Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Neurological Biomarkers Major Product Offerings
7.5.4 Roche Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Illumina
7.6.1 Illumina Company Summary
7.6.2 Illumina Business Overview
7.6.3 Illumina Neurological Biomarkers Major Product Offerings
7.6.4 Illumina Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.6.5 Illumina Key News & Latest Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Company Summary
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Neurological Biomarkers Major Product Offerings
7.7.4 Bio-Rad Laboratories Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.7.5 Bio-Rad Laboratories Key News & Latest Developments
7.8 QIAGEN
7.8.1 QIAGEN Company Summary
7.8.2 QIAGEN Business Overview
7.8.3 QIAGEN Neurological Biomarkers Major Product Offerings
7.8.4 QIAGEN Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.8.5 QIAGEN Key News & Latest Developments
7.9 Myriad RBM
7.9.1 Myriad RBM Company Summary
7.9.2 Myriad RBM Business Overview
7.9.3 Myriad RBM Neurological Biomarkers Major Product Offerings
7.9.4 Myriad RBM Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.9.5 Myriad RBM Key News & Latest Developments
7.10 Cisbio Bioassays
7.10.1 Cisbio Bioassays Company Summary
7.10.2 Cisbio Bioassays Business Overview
7.10.3 Cisbio Bioassays Neurological Biomarkers Major Product Offerings
7.10.4 Cisbio Bioassays Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.10.5 Cisbio Bioassays Key News & Latest Developments
7.11 Athena Diagnostics
7.11.1 Athena Diagnostics Company Summary
7.11.2 Athena Diagnostics Neurological Biomarkers Business Overview
7.11.3 Athena Diagnostics Neurological Biomarkers Major Product Offerings
7.11.4 Athena Diagnostics Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.11.5 Athena Diagnostics Key News & Latest Developments
7.12 BGI
7.12.1 BGI Company Summary
7.12.2 BGI Neurological Biomarkers Business Overview
7.12.3 BGI Neurological Biomarkers Major Product Offerings
7.12.4 BGI Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.12.5 BGI Key News & Latest Developments
7.13 Wuxi APP
7.13.1 Wuxi APP Company Summary
7.13.2 Wuxi APP Neurological Biomarkers Business Overview
7.13.3 Wuxi APP Neurological Biomarkers Major Product Offerings
7.13.4 Wuxi APP Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.13.5 Wuxi APP Key News & Latest Developments
7.14 Aepodia
7.14.1 Aepodia Company Summary
7.14.2 Aepodia Business Overview
7.14.3 Aepodia Neurological Biomarkers Major Product Offerings
7.14.4 Aepodia Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.14.5 Aepodia Key News & Latest Developments
7.15 Proteome Sciences
7.15.1 Proteome Sciences Company Summary
7.15.2 Proteome Sciences Business Overview
7.15.3 Proteome Sciences Neurological Biomarkers Major Product Offerings
7.15.4 Proteome Sciences Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.15.5 Proteome Sciences Key News & Latest Developments
7.16 Genewiz
7.16.1 Genewiz Company Summary
7.16.2 Genewiz Business Overview
7.16.3 Genewiz Neurological Biomarkers Major Product Offerings
7.16.4 Genewiz Neurological Biomarkers Sales and Revenue in Global (2018-2023)
7.16.5 Genewiz Key News & Latest Developments
8 Global Neurological Biomarkers Production Capacity, Analysis
8.1 Global Neurological Biomarkers Production Capacity, 2018-2029
8.2 Neurological Biomarkers Production Capacity of Key Manufacturers in Global Market
8.3 Global Neurological Biomarkers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neurological Biomarkers Supply Chain Analysis
10.1 Neurological Biomarkers Industry Value Chain
10.2 Neurological Biomarkers Upstream Market
10.3 Neurological Biomarkers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neurological Biomarkers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Neurological Biomarkers in Global Market
Table 2. Top Neurological Biomarkers Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Neurological Biomarkers Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Neurological Biomarkers Revenue Share by Companies, 2018-2023
Table 5. Global Neurological Biomarkers Sales by Companies, (K Units), 2018-2023
Table 6. Global Neurological Biomarkers Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Neurological Biomarkers Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Neurological Biomarkers Product Type
Table 9. List of Global Tier 1 Neurological Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurological Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Neurological Biomarkers Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Neurological Biomarkers Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Neurological Biomarkers Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Neurological Biomarkers Sales (K Units), 2018-2023
Table 15. By Type - Global Neurological Biomarkers Sales (K Units), 2024-2029
Table 16. By Application ? Global Neurological Biomarkers Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Neurological Biomarkers Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Neurological Biomarkers Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Neurological Biomarkers Sales (K Units), 2018-2023
Table 20. By Application - Global Neurological Biomarkers Sales (K Units), 2024-2029
Table 21. By Region ? Global Neurological Biomarkers Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Neurological Biomarkers Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Neurological Biomarkers Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Neurological Biomarkers Sales (K Units), 2018-2023
Table 25. By Region - Global Neurological Biomarkers Sales (K Units), 2024-2029
Table 26. By Country - North America Neurological Biomarkers Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Neurological Biomarkers Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Neurological Biomarkers Sales, (K Units), 2018-2023
Table 29. By Country - North America Neurological Biomarkers Sales, (K Units), 2024-2029
Table 30. By Country - Europe Neurological Biomarkers Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Neurological Biomarkers Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Neurological Biomarkers Sales, (K Units), 2018-2023
Table 33. By Country - Europe Neurological Biomarkers Sales, (K Units), 2024-2029
Table 34. By Region - Asia Neurological Biomarkers Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Neurological Biomarkers Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Neurological Biomarkers Sales, (K Units), 2018-2023
Table 37. By Region - Asia Neurological Biomarkers Sales, (K Units), 2024-2029
Table 38. By Country - South America Neurological Biomarkers Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Neurological Biomarkers Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Neurological Biomarkers Sales, (K Units), 2018-2023
Table 41. By Country - South America Neurological Biomarkers Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Neurological Biomarkers Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Neurological Biomarkers Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Neurological Biomarkers Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Neurological Biomarkers Sales, (K Units), 2024-2029
Table 46. Thermo Fisher Scientific Company Summary
Table 47. Thermo Fisher Scientific Neurological Biomarkers Product Offerings
Table 48. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Thermo Fisher Scientific Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Neurological Biomarkers Product Offerings
Table 52. Merck Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Quest Diagnostics Company Summary
Table 55. Quest Diagnostics Neurological Biomarkers Product Offerings
Table 56. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Quest Diagnostics Key News & Latest Developments
Table 58. Abbott Company Summary
Table 59. Abbott Neurological Biomarkers Product Offerings
Table 60. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Abbott Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Neurological Biomarkers Product Offerings
Table 64. Roche Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Roche Key News & Latest Developments
Table 66. Illumina Company Summary
Table 67. Illumina Neurological Biomarkers Product Offerings
Table 68. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Illumina Key News & Latest Developments
Table 70. Bio-Rad Laboratories Company Summary
Table 71. Bio-Rad Laboratories Neurological Biomarkers Product Offerings
Table 72. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Bio-Rad Laboratories Key News & Latest Developments
Table 74. QIAGEN Company Summary
Table 75. QIAGEN Neurological Biomarkers Product Offerings
Table 76. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. QIAGEN Key News & Latest Developments
Table 78. Myriad RBM Company Summary
Table 79. Myriad RBM Neurological Biomarkers Product Offerings
Table 80. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Myriad RBM Key News & Latest Developments
Table 82. Cisbio Bioassays Company Summary
Table 83. Cisbio Bioassays Neurological Biomarkers Product Offerings
Table 84. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Cisbio Bioassays Key News & Latest Developments
Table 86. Athena Diagnostics Company Summary
Table 87. Athena Diagnostics Neurological Biomarkers Product Offerings
Table 88. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Athena Diagnostics Key News & Latest Developments
Table 90. BGI Company Summary
Table 91. BGI Neurological Biomarkers Product Offerings
Table 92. BGI Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. BGI Key News & Latest Developments
Table 94. Wuxi APP Company Summary
Table 95. Wuxi APP Neurological Biomarkers Product Offerings
Table 96. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Wuxi APP Key News & Latest Developments
Table 98. Aepodia Company Summary
Table 99. Aepodia Neurological Biomarkers Product Offerings
Table 100. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Aepodia Key News & Latest Developments
Table 102. Proteome Sciences Company Summary
Table 103. Proteome Sciences Neurological Biomarkers Product Offerings
Table 104. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Proteome Sciences Key News & Latest Developments
Table 106. Genewiz Company Summary
Table 107. Genewiz Neurological Biomarkers Product Offerings
Table 108. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Genewiz Key News & Latest Developments
Table 110. Neurological Biomarkers Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global Neurological Biomarkers Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Neurological Biomarkers Production by Region, 2018-2023 (K Units)
Table 113. Global Neurological Biomarkers Production by Region, 2024-2029 (K Units)
Table 114. Neurological Biomarkers Market Opportunities & Trends in Global Market
Table 115. Neurological Biomarkers Market Drivers in Global Market
Table 116. Neurological Biomarkers Market Restraints in Global Market
Table 117. Neurological Biomarkers Raw Materials
Table 118. Neurological Biomarkers Raw Materials Suppliers in Global Market
Table 119. Typical Neurological Biomarkers Downstream
Table 120. Neurological Biomarkers Downstream Clients in Global Market
Table 121. Neurological Biomarkers Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Neurological Biomarkers Segment by Type in 2022
Figure 2. Neurological Biomarkers Segment by Application in 2022
Figure 3. Global Neurological Biomarkers Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Neurological Biomarkers Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Neurological Biomarkers Revenue, 2018-2029 (US$, Mn)
Figure 7. Neurological Biomarkers Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Neurological Biomarkers Revenue in 2022
Figure 9. By Type - Global Neurological Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Neurological Biomarkers Revenue Market Share, 2018-2029
Figure 11. By Type - Global Neurological Biomarkers Sales Market Share, 2018-2029
Figure 12. By Type - Global Neurological Biomarkers Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Neurological Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Neurological Biomarkers Revenue Market Share, 2018-2029
Figure 15. By Application - Global Neurological Biomarkers Sales Market Share, 2018-2029
Figure 16. By Application - Global Neurological Biomarkers Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Neurological Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Neurological Biomarkers Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Neurological Biomarkers Revenue Market Share, 2018-2029
Figure 20. By Region - Global Neurological Biomarkers Sales Market Share, 2018-2029
Figure 21. By Country - North America Neurological Biomarkers Revenue Market Share, 2018-2029
Figure 22. By Country - North America Neurological Biomarkers Sales Market Share, 2018-2029
Figure 23. US Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Neurological Biomarkers Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Neurological Biomarkers Sales Market Share, 2018-2029
Figure 28. Germany Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 29. France Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Neurological Biomarkers Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Neurological Biomarkers Sales Market Share, 2018-2029
Figure 37. China Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 41. India Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Neurological Biomarkers Revenue Market Share, 2018-2029
Figure 43. By Country - South America Neurological Biomarkers Sales Market Share, 2018-2029
Figure 44. Brazil Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Neurological Biomarkers Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Neurological Biomarkers Sales Market Share, 2018-2029
Figure 48. Turkey Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Neurological Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 52. Global Neurological Biomarkers Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Neurological Biomarkers by Region, 2022 VS 2029
Figure 54. Neurological Biomarkers Industry Value Chain
Figure 55. Marketing Channels
